Markus Hecht

2.5k total citations
102 papers, 1.4k citations indexed

About

Markus Hecht is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Markus Hecht has authored 102 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 28 papers in Otorhinolaryngology and 24 papers in Surgery. Recurrent topics in Markus Hecht's work include Cancer Immunotherapy and Biomarkers (30 papers), Head and Neck Cancer Studies (28 papers) and Immunotherapy and Immune Responses (12 papers). Markus Hecht is often cited by papers focused on Cancer Immunotherapy and Biomarkers (30 papers), Head and Neck Cancer Studies (28 papers) and Immunotherapy and Immune Responses (12 papers). Markus Hecht collaborates with scholars based in Germany, China and United States. Markus Hecht's co-authors include Rainer Fietkau, Luitpold Distel, Udo S. Gaipl, Benjamin Frey, Rainer Fietkau, Marlen Haderlein, Michael Rückert, Maike Büttner‐Herold, Arndt Hartmann and Lisa Deloch and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Markus Hecht

98 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Hecht Germany 23 891 370 336 289 240 102 1.4k
Deborah Jean Lee Wong United States 14 887 1.0× 239 0.6× 408 1.2× 396 1.4× 321 1.3× 53 1.6k
Vito Rodolico Italy 24 457 0.5× 487 1.3× 258 0.8× 215 0.7× 339 1.4× 79 1.6k
Periklis Foukas Greece 21 1.2k 1.3× 447 1.2× 970 2.9× 261 0.9× 285 1.2× 76 2.2k
Maike Büttner‐Herold Germany 25 703 0.8× 369 1.0× 775 2.3× 241 0.8× 208 0.9× 109 1.7k
Dirk Van Gestel Belgium 20 439 0.5× 178 0.5× 109 0.3× 502 1.7× 230 1.0× 88 1.2k
Susannah G. Ellsworth United States 22 1.3k 1.4× 123 0.3× 346 1.0× 590 2.0× 391 1.6× 68 1.9k
Chrisann Kyi United States 14 945 1.1× 206 0.6× 550 1.6× 200 0.7× 123 0.5× 41 1.3k
Angela Santoro Italy 30 661 0.7× 780 2.1× 150 0.4× 356 1.2× 428 1.8× 195 2.8k
Sang‐Hue Yen Taiwan 23 512 0.6× 390 1.1× 90 0.3× 315 1.1× 352 1.5× 52 1.8k
Sandra Schmitz Belgium 21 614 0.7× 389 1.1× 91 0.3× 385 1.3× 504 2.1× 67 1.4k

Countries citing papers authored by Markus Hecht

Since Specialization
Citations

This map shows the geographic impact of Markus Hecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hecht more than expected).

Fields of papers citing papers by Markus Hecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Hecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hecht. The network helps show where Markus Hecht may publish in the future.

Co-authorship network of co-authors of Markus Hecht

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Hecht. A scholar is included among the top collaborators of Markus Hecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Hecht. Markus Hecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lodde, Georg, Ulrike Leiter, Anja Gesierich, et al.. (2025). Clinical course of Merkel cell carcinoma: A DeCOG multicenter study of 1049 patients. European Journal of Cancer. 221. 115406–115406. 1 indexed citations
2.
Zhou, Jian‐Guo, Jie Yang, Haitao Wang, et al.. (2024). Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy. SHILAP Revista de lepidopterología. 3(1). e000128–e000128. 1 indexed citations
3.
Wang, Shixiang, Yi Xiong, Haitao Wang, et al.. (2024). TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 12(1). e008040–e008040. 7 indexed citations
4.
Tamaskovics, Bálint, Markus Hecht, Philipp Schubert, et al.. (2023). 944TiP Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial. Annals of Oncology. 34. S593–S593. 1 indexed citations
5.
Rieckmann, Thorsten, Markus Hecht, Antoniu‐Oreste Gostian, et al.. (2023). Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells. Neoplasia. 45. 100944–100944. 2 indexed citations
6.
Rupp, Robin, Konstantinos Mantsopoulos, Matti Sievert, et al.. (2022). Factors Influencing the Outcome of Head and Neck Cancer of Unknown Primary (HNCUP). Journal of Clinical Medicine. 11(10). 2689–2689. 3 indexed citations
7.
Frey, Benjamin, et al.. (2022). Influence of alectinib and crizotinib on ionizing radiation - in vitro analysis of ALK/ROS1-wildtype lung tissue cells. Neoplasia. 27. 100780–100780. 3 indexed citations
8.
Deloch, Lisa, et al.. (2022). Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts. Strahlentherapie und Onkologie. 199(12). 1128–1139. 15 indexed citations
9.
Fietkau, Rainer, et al.. (2021). Palbociclib Induces Senescence in Melanoma and Breast Cancer Cells and Leads to Additive Growth Arrest in Combination With Irradiation. Frontiers in Oncology. 11. 740002–740002. 39 indexed citations
10.
Hecht, Markus, et al.. (2021). PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation. Genes. 12(6). 849–849. 16 indexed citations
11.
Wimmer, Sebastian, Lisa Deloch, Michael Häder, et al.. (2021). Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells. International Journal of Molecular Sciences. 22(17). 9114–9114. 12 indexed citations
12.
Zhou, Jian‐Guo, Anna-Jasmina Donaubauer, Benjamin Frey, et al.. (2021). Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 9(2). e001845–e001845. 40 indexed citations
13.
Zhou, Jian‐Guo, Bo Liang, Jianguo Liu, et al.. (2021). Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy. Cells. 10(5). 977–977. 31 indexed citations
14.
Weißmann, Thomas, Florian Putz, Sebastian Lettmaier, et al.. (2021). Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer—Comparison of a Prospective Trial with a Revised Simulated Contouring Approach. Journal of Clinical Medicine. 10(20). 4653–4653. 1 indexed citations
15.
16.
Hofmann, Alexander, Florian Putz, Maike Büttner‐Herold, et al.. (2021). Increase in non-professional phagocytosis during the progression of cell cycle. PLoS ONE. 16(2). e0246402–e0246402. 6 indexed citations
17.
Hecht, Markus, Manfred Schmidt, Marlen Haderlein, et al.. (2021). Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer. Cancers. 14(1). 148–148. 14 indexed citations
18.
19.
Hecht, Markus, D Hahn, Matthias Hautmann, et al.. (2020). Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer. BMC Cancer. 20(1). 933–933. 9 indexed citations
20.
Hecht, Markus, et al.. (2020). Dual mTOR/DNA-PK Inhibitor CC-115 Induces Cell Death in Melanoma Cells and Has Radiosensitizing Potential. International Journal of Molecular Sciences. 21(23). 9321–9321. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deborah Jean Lee Wong Breakdown of academic impact, for papers by Vito Rodolico Breakdown of academic impact, for papers by Periklis Foukas Breakdown of academic impact, for papers by Maike Büttner‐Herold Breakdown of academic impact, for papers by Dirk Van Gestel Breakdown of academic impact, for papers by Susannah G. Ellsworth Breakdown of academic impact, for papers by Chrisann Kyi Breakdown of academic impact, for papers by Angela Santoro Breakdown of academic impact, for papers by Sang‐Hue Yen Breakdown of academic impact, for papers by Sandra Schmitz
Rankless by CCL
2026